Scientific Opinion on the substantiation of health claims related to chitosan and reduction in body weight (ID 679, 1499), maintenance of normal blood LDL-cholesterol concentrations (ID 4663), reduction of intestinal transit time (ID 4664) and reduction of inflammation (ID 1985) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 9, Issue 6, 2011, Pages

[No Author Info available]

Author keywords

body weight; Chitosan; fibre; health claims; inflammation; intestinal transit time; LDL cholesterol

Indexed keywords

EID: 85029840370     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2214     Document Type: Article

References (22)

1. Colombo P and Sciutto AM, 1996. Nutritional aspects of chitosan employment in hypocaloric diet. Acta Toxicologica et Therapeutica, 16, 287–302.
2. Deuchi K, Kanauchi O, Imasato Y and Kobayashi E, 1995. Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high fat diet. Bioscience Biotechnology and Biochemistry, 59, 781–785.
3. Ernst E and Pittler MH, 2000. Chitosan as a treatment for body weight reduction. A meta-analysis. In: Chitosan Per Os: From Dietary Supplement to Drug Carrier. Ed Muzzarelli RAA. Atec, Grottammare.
4. Girola M, de Bernardi M, Contos S, Tripodi S, Ventura P, Guarino C and Marletta M, 1996. Dose effect in lipid-lowering activity of a new dietary integrator (chitosan, Garcinia cambogia extract and chrome) [Effetto della dose sull'attivita antilipemica di un nuovo integratore dietetico (chitosano, estratto di Garcinia cambogia e cromo)]. Acta Toxicologica et Therapeutica, 17, 25–40.
5. Giustina A and Ventura P, 1995. Weight-reducing regimens in obese subjects: effects of a new dietary fiber integrator. Acta Toxicologica et Therapeutica, 16, 199–214.
6. Guerciolini R, Radu-Radulescu L, Boldrin M, Dallas J and Moore R, 2001. Comparative Evaluation of Fecal Fat Excretion Induced by Orlistat and Chitosan. Obesity Research, 9, 364–367.
7. Ho SC, Tai ES, Eng PH, Tan CE and Fok AC, 2001. In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Singapore Medical Journal, 42, 6–10.
8. Jull AB, Ni Mhurchu C, Bennett DA, Dunshea-Mooij CA and Rodgers A, 2008. Chitosan for overweight or obesity (Review). Cochrane Database of Systematic Reviews, 3, CD003892.
9. Kaats GR, Michalek JE and Preuss HG, 2006. Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol. Journal of the American College of Nutrition, 25, 389–394.
10. Macchi G, 1996. A new approach to the treatment of obesity: chitosan's effects on body weight reduction and plasma cholesterol's levels. Acta Toxicologica et Therapeutica, 17, 303–322.
11. Ni Mhurchu C, Poppitt S, McGill A-T, Leahy F, Bennett D, Lin R, Ormrod D, Ward L, Strik C, Rodgers A and Collaboration. obotE, 2004. The effect of the dietary supplement, chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. International Journal of Obesity, 28, 1149–1156.
12. Ni Mhurchu C, Dunshea-Mooij CA, Bennett D and Rodgers A, 2005. Chitosan for overweight or obesity. Cochrane Database of Systematic Reviews, CD003892.
13. Pittler MH, Abbot NC, Harkness EF and Ernst E, 1999. Randomized, double-blind trial of chitosan for body weight reduction. European Journal of Clinical Nutrition, 53, 379–381.
14. Schiller RN, Barrager E, Schauss AG and Nichols EJ, 2001. A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals. Journal of American Nutraceutical Association, 4, 42–49.
15. Sciutto AM and Colombo P, 1995. Lipid-lowering effect of chitosan dietary integrator and hypocaloric diet in obese subjects. Acta Toxicologica et Therapeutica, 16, 215–230.
16. Sugano M, Fujikawa T, Hiratsuji Y, Nakashima K, Fukuda N and Hasegawa Y, 1980. A novel use of chitosan as a hypocholesterolemic agent in rats. American Journal of Clinical Nutrition, 33, 787–793.
17. Veneroni G, Veneroni F, Contos S, Tripodi S, de Bernardi M, Guarino C and Marietta M, 1996. Effect of a new chitosan on hyperlipidemia and overweight in obese patients. In: Chitin enzymology. Ed Muzzarelli RAA. Atec, Grottammare, 63–67.
18. Williams AR, 1998. A double-blind, placebo-controlled evaluation of the effects of RW94 on the body weight of both overweight and obese healthy volunteers. Current Medical Research and Opinion, 14, 243–249.
19. Woodgate DE and Conquer JA, 2003. Effects of a Stimulant-Free Dietary Supplement on Body Weight and Fat Loss in Obese Adults: A Six-Week Exploratory Study Current Therapeutic Research, 64, 248–262
20. Wuolijoki E, Hirvela T and Ylitalo P, 1999. Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods and Findings in Experimental Clinical Pharmacology, 21, 357–361.
21. Zacour A, Silva M, Cecon P, Bambirra E and Vieira E, 1992. Effect of dietary chiton on cholesterol absorption and metabolism in rats. Journal of Nutritional Science and Vitaminology, 38, 609–613.
22. Zahorska-Markiewicz B, Krotkiewski M, Olszanecka-Glinianowicz M and Zurakowski A, 2002. [Effect of chitosan in complex management of obesity]. Polski Merkuriusz Lekarski, 13, 129–132.